120 related articles for article (PubMed ID: 36710120)
1. Transarterial ethiodised oil marking before CT-guided renal cryoablation: evaluation of tumour visibility in various renal cell carcinoma subtypes.
Tsuji Y; Miura H; Hirota T; Ota Y; Yamashita M; Asai S; Fujihara A; Hongo F; Ukimura O; Yamada K
Clin Radiol; 2023 Apr; 78(4):279-285. PubMed ID: 36710120
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of arterial infusion of iodized oil on CT-guided cryoablation for renal cell carcinoma.
Kajiwara K; Yoshimatsu R; Nishimori M; Yamanishi T; Minamiguchi H; Karashima T; Inoue K; Awai K; Yamagami T
Minim Invasive Ther Allied Technol; 2021 Dec; 30(6):327-333. PubMed ID: 32134346
[TBL] [Abstract][Full Text] [Related]
3. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
[TBL] [Abstract][Full Text] [Related]
4. Preoperative lipiodol marking and its role on survival and complication rates of CT-guided cryoablation for small renal masses.
Hongo F; Yamada Y; Ueda T; Nakmura T; Naya Y; Kamoi K; Okihara K; Ichijo Y; Miki T; Yamada K; Ukimura O
BMC Urol; 2017 Jan; 17(1):10. PubMed ID: 28100214
[TBL] [Abstract][Full Text] [Related]
5. Comparison of cortico-medullary phase contrast-enhanced MDCT and T2-weighted MR imaging in the histological subtype differentiation of renal cell carcinoma: radiology-pathology correlation.
Halefoglu AM; Ozagari AA
Pol J Radiol; 2021; 86():e583-e593. PubMed ID: 34876939
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of renal cell carcinoma histological subtype and fuhrman grade using
Nakajima R; Nozaki S; Kondo T; Nagashima Y; Abe K; Sakai S
Eur Radiol; 2017 Nov; 27(11):4866-4873. PubMed ID: 28523353
[TBL] [Abstract][Full Text] [Related]
7. Differential radiologic characteristics of renal tumours on multiphasic computed tomography.
Ching BC; Tan HS; Tan PH; Toh CK; Kanesvaran R; Ng QS; Tan MH
Singapore Med J; 2017 May; 58(5):262-266. PubMed ID: 27090599
[TBL] [Abstract][Full Text] [Related]
8. Quantitative differentiation of minimal-fat angiomyolipomas from renal cell carcinomas using grating-based x-ray phase-contrast computed tomography: An ex vivo study.
Birnbacher L; Braunagel M; Willner M; Marschner M; De Marco F; Viermetz M; Auweter S; Notohamiprodjo S; Hellbach K; Notohamiprodjo M; Staehler M; Pfeiffer D; Reiser MF; Pfeiffer F; Herzen J
PLoS One; 2023; 18(4):e0279323. PubMed ID: 37058505
[TBL] [Abstract][Full Text] [Related]
9. The value of real-time contrast-enhanced ultrasound combined with CT enhancement in the differentiation of subtypes of renal cell carcinoma.
Liang RX; Wang H; Zhang HP; Ye Q; Zhang Y; Zheng MJ; Xue ES; Zhu YF
Urol Oncol; 2021 Dec; 39(12):837.e19-837.e28. PubMed ID: 34654644
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of CT-guided cryoablation after lipiodol marking and embolization for RCC.
Kajiwara K; Yoshimatsu R; Komoto M; Maeda H; Yamanishi T; Minamiguchi H; Karashima T; Inoue K; Awai K; Yamagami T
Minim Invasive Ther Allied Technol; 2022 Aug; 31(6):923-929. PubMed ID: 35057706
[TBL] [Abstract][Full Text] [Related]
11. Use of specific contrast-enhanced CT regions of interest to differentiate renal oncocytomas from small clear cell and chromophobe renal cell carcinomas.
Qu JY; Jiang H; Wang XF; Song XH; Hao CJ
Diagn Interv Radiol; 2022 Nov; 28(6):555-562. PubMed ID: 36550755
[TBL] [Abstract][Full Text] [Related]
12. Effect of lipiodol marking before CT-guided cryoablation on the outcome of sporadic renal cell carcinoma.
Ushijima Y; Okamoto D; Fujita N; Ishimatsu K; Wada N; Takao S; Murayama R; Itoyama M; Ishigami K
Diagn Interv Radiol; 2024 Mar; 30(2):117-123. PubMed ID: 38164892
[TBL] [Abstract][Full Text] [Related]
13. Comparison of type I and II papillary renal cell carcinoma (RCC) and clear cell RCC.
Waldert M; Haitel A; Marberger M; Katzenbeisser D; Ozsoy M; Stadler E; Remzi M
BJU Int; 2008 Nov; 102(10):1381-4. PubMed ID: 18782311
[TBL] [Abstract][Full Text] [Related]
14. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
Halefoglu AM; Ozagari AA
Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
[TBL] [Abstract][Full Text] [Related]
15. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
[TBL] [Abstract][Full Text] [Related]
16. CT evaluation of patent artery after percutaneous cryoablation of renal cell carcinoma.
Kajita S; Iguchi T; Hiraki T; Matsui Y; Tomita K; Uka M; Tanaka T; Araki M; Gobara H; Kanazawa S
Diagn Interv Imaging; 2021 Dec; 102(12):753-758. PubMed ID: 34144934
[TBL] [Abstract][Full Text] [Related]
17. Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT.
Sasaguri K; Takahashi N; Gomez-Cardona D; Leng S; Schmit GD; Carter RE; Leibovich BC; Kawashima A
AJR Am J Roentgenol; 2015 Nov; 205(5):999-1007. PubMed ID: 26496547
[TBL] [Abstract][Full Text] [Related]
18. Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT.
Gentili F; Bronico I; Maestroni U; Ziglioli F; Silini EM; Buti S; de Filippo M
Radiol Med; 2020 Dec; 125(12):1280-1287. PubMed ID: 32385827
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of Clear Cell Renal Cell Carcinoma from other Renal Cell Carcinoma Subtypes and Benign Oncocytoma Using Quantitative MDCT Enhancement Parameters.
Moldovanu CG; Petresc B; Lebovici A; Tamas-Szora A; Suciu M; Crisan N; Medan P; Buruian MM
Medicina (Kaunas); 2020 Oct; 56(11):. PubMed ID: 33126571
[No Abstract] [Full Text] [Related]
20. Differentiating papillary type I RCC from clear cell RCC and oncocytoma: application of whole-lesion volumetric ADC measurement.
Paschall AK; Mirmomen SM; Symons R; Pourmorteza A; Gautam R; Sahai A; Dwyer AJ; Merino MJ; Metwalli AR; Linehan WM; Malayeri AA
Abdom Radiol (NY); 2018 Sep; 43(9):2424-2430. PubMed ID: 29520425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
